AzTrials
AzTrials

PrematureNCT04203589

Explorer Babies Early Intervention Program

A study testing The Explorer Baby Early Intervention Program and Neurodevelopmental Therapy in people with Premature and Developmental Disability, run by Marmara University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Premature babies have a high risk of adverse developmental outcomes. Early intervention approaches are applied to reduce these adverse outcomes or support of developmental delay. Early intervention approaches may vary depending on developmental priorities. Read more about this study

Who is it for?
Ages Up to 6 months
What is being tested?
The Explorer Baby Early Intervention Program and Neurodevelopmental Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jun 2018to 30 Apr 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 6 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Born before than 33 weeks

Who cannot join

  • congenital malformations, all levels of asphyxia, intracranial hemorrhage, periventricular leukomalacia.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Marmara University

    Istanbul, 34854

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of New Holistic Early Intervention Approach (Explorer Babies): a Randomized Controlled Study

Premature babies have a high risk of adverse developmental outcomes. Early intervention approaches are applied to reduce these adverse outcomes or support of developmental delay. Early intervention approaches may vary depending on developmental priorities. While some early intervention methods can consider body structured findings such as posture, tonus, muscle power, others may consider coaching family, enrichment of the environment. The explorer baby program is developed based on the trial and error process. The program tries to find an answer to a unique question: "how trial behavior in infants can be increased and which behaviors of the infants should be supported to increase their trial process?" The Explorer baby program tries to increase exploratory motor behaviors to facilitate development. For this aim, the program tries to explain how a baby learns new skills such as rolling, sitting, babbling, playing peek a boo, etc. in all domains of development while the baby lives in their natural environment. This study aims to investigate the effect of the explorer baby early intervention program.

Read the detailed description

The aim of the study is to investigate the effect of Explorer Baby Early Intervention Program on explorative motor behaviors, motor, language, and cognitive skills. The study is designed as a randomized controlled trial in which infants and their families are randomly assigned to the intervention group (Explorer Baby) or control group (neurodevelopmental therapy), stratified by birth weeks and educational level of the mother.

There is no developmental support program as standard care in Turkey for premature babies. So that neither intervention nor the control group doesn't take any other support. There will be an average of six intervention sessions during the 6 months intervention period. The assessments will take before intervention (T0), after 3 months after T0 (T1) and after six months after T0 (T2), corrected age one (T3), corrected age two (T4).

Intervention: EXPLORatory motor behavior based Early Intervention Program (Explorer Baby) is a developmental support program for babies and their families. Parents visit the early intervention center with their babies in a variable frequency. The first step of the program is to build up interaction between therapists and parents; worries of parents for the development of their babies, knowledge about child development, knowledge about play behaviors, how babies learn new skills, age-specific requirements of babies, build up interaction with babies and family members, describing blocks for development.

The second step is setting the play in the natural environment working with the family; how do families describe the play? If families want to support the ability of their babies kicking, reaching, rolling, communicate, or social interaction how should they organize the playground? Showing families some examples of enrichment of playground for specific aims.

The third step is observing babies' reactions; how do families motivate their babies for play? How do families encourage their babies for self-starting explorative behaviors? How do parents support making the voice of the baby more if the play context is meaningful for creating a voice? The program doesn't give specific play homework to improve specific skills. The program tries to enrich parents' knowledge about the effect on the behavior of babies in meaningful situations.

The control Group: The control group will take neurodevelopmental therapy. Neurodevelopmental therapy is commonly accepted as traditional therapy.

Being tested
The Explorer Baby Early Intervention Program, Neurodevelopmental Therapy
Keywords
Premature, Developmental Disability, Motor Disorder, Cerebral Palsy, Early Intervention, developmental Support
Medical subject headings
Premature Birth, Developmental Disabilities, Cerebral Palsy, Motor Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Explorer Baby Early Intervention ProgramBehavioural

    Also called Explorer Baby

    Centered based intervention, once or twice a month, 6 months follow up

  • Neurodevelopmental TherapyOther

    Also called Bobath

    Centered based intervention, once or twice a month, 6 months follow up

Study groups in NCT04203589
Study groupRoleWhat they receive
The Explorer Early Intervention ProgramExperimentalThe Explorer Early Intervention Program is used in this group.
Receives: Behavioral: The Explorer Baby Early Intervention Program
Neurodevelopmental TherapyActive comparatorNeurodevelopmental therapy is used in these group by two experienced and certificated physiotherapist
Receives: Other: Neurodevelopmental Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III)

    The Bayley III is assessing "Cognitive, Receptive Language, Expressive Language, Fine Motor, Gross Motor". Bayley III has a raw score, scale score, composite score, and growth percentile score. All of these scores will be given in the study. But only, the growth percentage score will be discussed as both the subareas and the total score as the primary outcome. Because only the percentage of growth gives the baby's level of development exactly day by day. The percentile score is between 0 and 100. A higher score means improvement is better. The changes in the growth percentage in pre-test and post-test (T0-T1, T1-T2, T0-T2) will be examined in-group. Also, the growth percentage scores of two groups will be compared before, during and after the therapy (intergroup). This tool will be used to assess the change between the three-time points.

    Measured: This tool will be used to assess the change between the three-time points. These time points are before therapy (T0), during therapy (T1 - 3 months after T0) and after therapy (T2 - 6 months after T0)

Secondary outcomes (3)
  1. Age and Stage Questionnaire 2 (ASQ-2)

    The Ages and Stages Questionnaire 2 (ASQ-2) is a widely used screening tool for infants and young children's development assessing development in five domains: Communication, Gross Motor, Fine Motor, Problem Solving and Personal Social. It is is originally a parent-completed questionnaire and it includes six questions for every developmental area. There are three options for the answer "Yes (10 points), Sometimes (5 points), No (0 points)". The raw score is between 0 to 60 points. High points mean better development. The study will use the raw score of all developmental areas. The age range of ASQ-2 is 3 months to 72 months meaning the ASQ-2 will not be used for children younger than 3 months. Post-tests (T1-T2) results will be used for discrimination (according to the parent's view) between children with developmental delays and developing typically in two groups.

    Measured: This tool will be used to assess the change between the three-time points. These time points are before therapy (T0), during therapy (T1 - 3 months after T0) and after therapy (T2 - 6 months after T0)

  2. Parent Stress Index-4-Short Form (PSI SF-4)

    The questionnaire is assessing "Parental Distress, Parent-Child Dysfunctional Interaction, Difficult Child" subheadings. High points are mean high-stress behaviour. The raw score is between 36 to 180 points. There are no cut scores in the Turkish version of PSI-4 SF. The changes in the raw scores in pre-test and post-test (T0-T1, T1-T2, T0-T2) will be examined in-group. Also, the raw scores of two groups will be compared before, during and after the therapy (intergroup). This tool will be used to assess the change between the three-time points.

    Measured: This tool will be used to assess the change between the three-time points. These time points are before therapy (T0), during therapy (T1 - 3 months after T0) and after therapy (T2 - 6 months after T0)

  3. Infant Movement Motivation Questionnaire

    The Questionnaire is assessing four subheadings with 27 items: "Activity, exploration, motivation, adaptability". There are no cut scores in these in the Turkish version of the questionnaire. High points mean better development. The raw score is between 27 to 135 points. The changes in the raw scores in pre-test and post-test (T0-T1, T1-T2, T0-T2) will be examined in-group. Also, the raw scores of two groups will be compared before, during and after the therapy (intergroup). This tool will be used to assess the change between the three-time points.

    Measured: This tool will be used to assess the change between the three-time points. These time points are before therapy (T0), during therapy (T1 - 3 months after T0) and after therapy (T2 - 6 months after T0)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2019
  2. Study start1 Jun 2018
  3. Primary completion1 Sep 2019
  4. Study completion30 Apr 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A parallel randomized controlled study
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04203589
Sponsor's protocol ID
09.2017.729
Status last verified
Sep 2020
First submitted
21 Nov 2019
Last updated
4 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The study will share the outcomes of statistics by using tables, figures.

Publications

  • Babik I, Galloway JC, Lobo MA. Infants Born Preterm Demonstrate Impaired Exploration of Their Bodies and Surfaces Throughout the First 2 Years of Life. Phys Ther. 2017 Sep 1;97(9):915-925. doi: 10.1093/ptj/pzx064.

    PubMed 28605484
  • de Campos AC, Savelsbergh GJ, Rocha NA. What do we know about the atypical development of exploratory actions during infancy? Res Dev Disabil. 2012 Nov-Dec;33(6):2228-35. doi: 10.1016/j.ridd.2012.06.016. Epub 2012 Jul 21.

    PubMed 22820063
  • Altunalan T, Sari Z, Dogan TD, Hacifazlioglu NE, Akman I, Altintas T, Uzer S, Akcakaya NH. Early developmental support for preterm infants based on exploratory behaviors: A parallel randomized controlled study. Brain Behav. 2023 Nov;13(11):e3266. doi: 10.1002/brb3.3266. Epub 2023 Oct 5.

    PubMed 37798860

Questions about this trial

What is this clinical trial studying?

A study testing The Explorer Baby Early Intervention Program and Neurodevelopmental Therapy in people with Premature and Developmental Disability, run by Marmara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) (time frame: This tool will be used to assess the change between the three-time points. These time points are before therapy (T0), during therapy (T1 - 3 months after T0) and after therapy (T2 - 6 months after T0)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04203589, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in